Table 1 Demographic data for patients participated in the study
Presumed predictor | Patients receiving TPM |
|---|---|
Age (years) | 26.2 ± 10.3 |
Sex | 8 males (40 %); 12 females (60 %) |
Disease | 10 (50%) patients suffered epilepsy and the other 10 (50%) suffered migraine |
Stable TPM dose | 7 (35%) used 50 mg/day, 8 (40%) used 100 mg/day, and 5 (25%) used 200 mg/day |